Standout Papers
Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
2003 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
2016
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2011 Standout
Randomized Pilot Trial of Bariatric Surgery Versus Intensive Medical Weight Management on Diabetes Remission in Type 2 Diabetic Patients Who Do NOT Meet NIH Criteria for Surgery and the Role of Soluble RAGE as a Novel Biomarker of Success
2014
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Patient, surgeon, and healthcare purchaser views on the use of decision and communication aids in orthopaedic surgery: a mixed methods study
2014
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Spontaneous regression of human melanoma/nonmelanoma skin cancer: Association with infiltrating CD4+ T cells
1995
Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
1996
Progress in human tumour immunology and immunotherapy
2001 Nature
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
1998 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Inflammation and cancer
2002 StandoutNature
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Tumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
1992
The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells
2013
Modular and tunable biological feedback control using a de novo protein switch
2019 StandoutNatureNobel
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
The Principles of Engineering Immune Cells to Treat Cancer
2017
Impaired tumor growth in colony-stimulating factor 1 (CSF-1)-deficient, macrophage-deficientop/op mouse: Evidence for a role of CSF-1-dependent macrophages in formation of tumor stroma
1996
Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity
1995
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Decision aids for people facing health treatment or screening decisions
2014
Choosing treatment and screening options congruent with values: Do decision aids help? Sub-analysis of a systematic review
2015
Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction
1990
Human tumor antigens recognized by T-cells
1997
Cancer vaccines based on the identification of genes encoding cancer regression antigens
1997
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
2008
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
2011
Angiogenesis in life, disease and medicine
2005 StandoutNature
Human tumor antigens for cancer vaccine development
1999
Shared Decision Making in Patients with Osteoarthritis of the Hip and Knee
2013
Cancer immunotherapy comes of age
2011 StandoutNature
Adoptive T Cell Immunotherapy For Cancer
2015
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells
1991
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
Inhibition of death receptor signals by cellular FLIP
1997 StandoutNature
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Adoptive cell therapy for the treatment of patients with metastatic melanoma
2009
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999
IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases.
1995
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
1996
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 StandoutNobel
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
1994
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules
2004
Association Between Bariatric Surgery and Long-term Survival
2015
Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70
2000 StandoutNobel
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
1991 StandoutScience
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Preventing Complications of Central Venous Catheterization
2003 Standout
B7x: A widely expressed B7 family member that inhibits T cell activation
2003 StandoutNobel
Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.
1996
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2
1994
Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides.
1995
Decision aids for people facing health treatment or screening decisions
2017 Standout
Therapeutic Targeting of the Tumor Microenvironment
2021
Death Receptors: Signaling and Modulation
1998 StandoutScience
Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.
1994
Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
1996
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
The Basic Science of Gene Therapy
1993 Science
Chimeric Antigen Receptor Therapy
2018 Standout
Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomas.
1990
Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
2002
The future of immune checkpoint therapy
2015 StandoutScienceNobel
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
1994
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 StandoutScienceNobel
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
1996 Science
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
1997 StandoutScience
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
1994
Neoantigens in cancer immunotherapy
2015 StandoutScience
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 StandoutScienceNobel
IL-2: The First Effective Immunotherapy for Human Cancer
2014
T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells
2002
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
2002 StandoutNobel
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Works of Steven Bock being referenced
A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy.
1990
Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial
2016
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
1988 Standout
A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes
2013
Randomized Trial of a Video‐Based Patient Decision Aid for Bariatric Surgery
2011
Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes.
1990
Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice.
1991